Amy M. Meadowcroft

Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis

Ajay Singh, Kevin Carroll, John J.V. McMurray et al. · New England Journal of Medicine · 2021 · 211 citations · Full text

Four-Week Studies of Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia

Louis Holdstock, Amy M. Meadowcroft, Rayma Maier et al. · Journal of the American Society of Nephrology · 2015 · 189 citations

Hemodialysis Study, Dialysis Therapy, Pharmacotherapy +16

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis

Amy M. Meadowcroft, Borut Čižman, Louis Holdstock et al. · Clinical Kidney Journal · 2018 · 103 citations · Full text

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease

Louis Holdstock, Borut Čižman, Amy M. Meadowcroft et al. · Clinical Kidney Journal · 2018 · 73 citations · Full text

Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients

Ajay Singh, Borut Čižman, Kevin Carroll et al. · JAMA Internal Medicine · 2022 · 70 citations · Full text